-
341
A Case of Subacute Cutaneous Lupus Erythematosus in a Patient with Mixed Connective Tissue Disease: Successful Treatment with Plasmapheresis and Rituximab
Published 2013-01-01“…A 30-year-old woman affected by Mixed Connective Tissue Disease with scleroderma spectrum developed a facial eruption, a clinical and histological characteristic of subacute cutaneous lupus erythematosus (SCLE). Speckled anti-nuclear antibodies, high-titer anti-ribonucleoprotein1, anti-Sm, anti-Cardiolipin (aCL) IgG/IgM, and anti-Ro/SSA antibodies were positive. …”
Get full text
Article -
342
Why is it so difficult to understand why we don’t understand human systemic lupus erythematosus? Contemplating facts, conflicts, and impact of “the causality cascade paradigm”
Published 2025-01-01Subjects: “…systemic lupus erythematosus (SLE)…”
Get full text
Article -
343
Principios físicos y avances recientes de la termografía infrarroja en odontología
Published 2021-12-01Subjects: Get full text
Article -
344
Safety of Cyclophosphamide Therapy in Autoimmune Rheumatic Diseases
Published 2019-01-01Subjects: Get full text
Article -
345
Case report: Rituximab combined with plasma exchange treatment for systemic lupus erythematosus complicated with thrombotic microangiopathy and non-cirrhotic portal hypertension
Published 2025-01-01Subjects: “…systemic lupus erythematosus…”
Get full text
Article -
346
-
347
Racial differences in clinical trial perceptions among a large, predominantly Black cohort of people with systemic lupus erythematosus in the Southeastern USA
Published 2025-01-01“…Lupus Science and Medicine…”
Get full text
Article -
348
-
349
The effect of pro-inflammatory cytokines on the development of atherosclerosis in systemic lupus erythematosus patients: ultrasonographic assessment of intimal medial thickness and resistive index
Published 2025-01-01Subjects: “…Systemic lupus erythematosus…”
Get full text
Article -
350
-
351
Collapsing glomerulopathy associated with parvovirus B19 and systemic lupus erythematosus in a patient with APOL1 high-risk variant for nephropathy
Published 2025-01-01Subjects: Get full text
Article -
352
Exploring the shared mechanism of fatigue between systemic lupus erythematosus and myalgic encephalomyelitis/chronic fatigue syndrome: monocytic dysregulation and drug repurposing
Published 2025-01-01Subjects: “…systemic lupus erythematosus…”
Get full text
Article -
353
Prolactin Levels Correlate with Abnormal B Cell Maturation in MRL and MRL/lpr Mouse Models of Systemic Lupus Erythematosus-Like Disease
Published 2013-01-01“…In this study, our aims were to determine the level of PRL receptor expression during bone-marrow B-cell development and to assess whether the presence of high PRL serum concentrations influences absolute numbers of developing populations and disease outcome in lupus-prone murine models. We observed that the PRL-receptor is expressed in early bone-marrow B-cell; the expression in lupus-prone mice, which had the highest level of expression in pro-B cells and immature cells, differed from that in wild-type mice. …”
Get full text
Article -
354
Association of disease activity with programmed cell death 1 and its ligand programmed cell death ligand 1 expressions in lupus patients
Published 2022-01-01Subjects: Get full text
Article -
355
Exploring cardiovascular implications in systemic lupus erythematosus: A holistic analysis of complications, diagnostic criteria, and therapeutic modalities, encompassing pharmacological and adjuvant approaches
Published 2024-11-01Subjects: “…systemic lupus erythematosus…”
Get full text
Article -
356
Extracellular HMGB1 Induced Glomerular Endothelial Cell Injury via TLR4/MyD88 Signaling Pathway in Lupus Nephritis
Published 2021-01-01“…These results suggested that extracellular HMGB1 might involve in GEC injury by activating the TLR4/MyD88 signaling pathway in LN, which provided novel insights and potential therapeutic target for the treatment of lupus nephritis.…”
Get full text
Article -
357
Adalimumab (TNFα Inhibitor) Therapy Exacerbates IgA Glomerulonephritis Acute Renal Injury and Induces Lupus Autoantibodies in a Psoriasis Patient
Published 2013-01-01“…We report a patient with extensive psoriasis presenting with renal failure and seropositive lupus markers without classical lupus nephritis after 18 months treatment with adalimumab. …”
Get full text
Article -
358
Deranged Bioenergetics and Defective Redox Capacity in T Lymphocytes and Neutrophils Are Related to Cellular Dysfunction and Increased Oxidative Stress in Patients with Active Systemic Lupus Erythematosus
Published 2012-01-01“…Urinary excretion of N-benzoyl-glycyl-Nε-(hexanonyl)lysine, a biomarker of oxidative stress, was higher in 26 patients with active systemic lupus erythematosus (SLE) than in 11 non-SLE patients with connective tissue diseases and in 14 healthy volunteers. …”
Get full text
Article -
359
MiR-223 within neutrophil axis promotes Th17 expansion by PI3K-AKT pathway in systemic lupus erythematosus
Published 2025-02-01Subjects: “…Systemic lupus erythematous…”
Get full text
Article -
360